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Backgrounds:
Liver transplantation with graft from living donor almost always accompanied by small-
for-size syndrome to various extent. The ratio, graft weight divided by recipient body
weight is believed to be useful to evaluate whether the graft is sufficient for the metabolic
demand of the recipient or not. In LDLT (living-donor liver transplantation), the GRWR
(graft weight to recipient body weight ratio) over 1.0% has been believed to be necessary.
Recently, we experienced the LDLT cases with good posttransplant outcome and survival
in spite of GRWR less than 0.8%.
Patients & Methods:
This study was done by retrospective chart review. From April 1997 to September 2005,
76 liver transplants were performed in Nagoya University. They include 45 LDLT for
adult recipients. Among them, 32 adults received right lobe graft [GRWR 1.04(median),
0.69 – 1.61]. The GRWR for 5 recipients is less than 0.8%. Pretransplant status, reason for
transplant, MELD score, ABO compatibility, GRWR, inflow modification (ligation of
splenic artery, partial portacaval shunt), HV anastomosis are reviewed. Posttransplant
parameters such as prothrombin time, serum bilirubin, amount of ascites, hospital stay
and survival are also analyzed.
Results:
The recipient profiles are summarized in the table. No recipient died in this group. Multiple
veins were reconstructed with all patients. One recipient suffered prolonged
hyperbilirubinemia, the possible cause of which is hemolytic anemia.
Conclusions:
The outcome of LDLT with small graft (GRWR < 0.8%) is satisfactory. Relatively low
MELD score and ideal ABO match has a possibility to contribute to the good results. The
difference in background of this report and previous reports declaring the importance of
GRWR over 1% includes graft type (left or lateral vs. right), recipient age (children vs.
adults) and era (improved management).
Recipients with small graft (GRWR <0.8%)
Age, Sex disease MELD ABO GRWR HVs Hospital Follow up
stay (days) (months)
55, M LC, HCC 15 identical *0.70 RHV, IRHV 50 21, alive
61, M HBV, HCC 16 identical +0.73 RHV, V8 39 11, alive
40, M HBV 20 compatible 0.78 RHV, V8 #115 6, alive
48, M HCV, HCC 11 compatible 0.69 RHV, V8 47 5.6, alive
59, M HCV, HCC 7 compatible +0.71 RHV, V8, 40 3.7 alive
IRHVx2
* portacaval shunt, +ligation of splenic artery, #prolonged hyperbilirubinemia
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Accidental ingestion of the Amanita phalloides mushroom is not uncommon in Poland. It
results in severe poisoning leading to profuse lver tissue necrosis. Liver transplantation
appears to be a life-saving procedure. It has to be undertaken urgently, as the period
between the onset of clinical symptoms and the fatal outcome does not usually exceed
48 hours. Distending this period is possible by means of intensive artificial liver support
therapy.
Clinical Material includes 9 critically ill comatous patients poisoned with Amanita
phalloides, admitted in the period 2000-2005. All of tem presented with deep metabolic
disorders and severe coagulopathy. All were listed for for super-urgent OLT, 6 underwent
albumin dialysis in the Promethaeus system. 3 patients recovered, 6 were transplanted
after waiting time ranging from 18 hrs to 5 days
Results: 3 of the dialysed patients improved and did no require OLT. 1 patient died in the
moment of reperfusion, 2 in the postoperative period. 3 transplanted patients fully
recovered.
Conclusion: Despite their extremely severe condition, Amanita poisoned patients can be
saved by OLT, if it is performed early enough. The Promethaeus system effectively
substitutes the liver function in the pre-transplant period, essentially delaying the fatal
outcome. In some cases it allows to avoid transplantation.
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Introduction: Two-stage liver transplantation, i.e. a procedure rendering a patient anhepatic
for a uncertain period of time before registration for emergent liver transplantation (LT),
has been seldom described in case of unstable fulminant liver failure, of massive hepatic
trauma or liver graft primary non function (PNF). In this report the authors describe their
experience in early liver graft removal after LT.
Patients and methods: Four young female patients (mean age 36 years) underwent LT
for various etiologies (PSC, HBV-HCC, alcohol-paracetamol, idiopathic cirrhosis). All
underwent early (day 0 to day 14) emergent total liver graft removal for various reasons
(uncontrollable preoperative hemorrhage, uncontrollable postoperative hemorrhage due
to PNF, graft necrosis due to vascular occlusion) and were registered for urgent reLT. All
went back to the ICU in an anhepatic state and underwent maximal supportive therapy
including CVVH and MARS support (1 case). Body temperature was maintained between
34 and 37°C.
Results: All patients survived until a cadaveric liver graft became available. In 3 cases
they underwent reLT after a mean anhepatic phase of 21 hours. Two survived without any
sequel and are alive and well at follow-up. The fourth patient experienced an anhepatic
phase of 84 hours. After reLT, the patient fully recovered from the neurologic point of vue
and was extubated. She eventually died from multiple organ failure 14 days after reLT.
Discussion: These cases illustrate that survival in anhepatic state is possible for at least 24
hrs. The potential full neurologic recovery after 84 hours of anhepatic state (the longest
ever reported to date) raises several questions on the pathogenesis of intracranial
hypertension in acute liver failure, reinforcing the “toxic liver” hypothesis in the etiology
of brain edema in this setting.
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Background and Objective: Acute leukemia(AL) following solid organ transplantation is rare with
only 10 cases of AL being reported, including six cases of acute myeloid leukemia after liver
transplantation. Chronic myeloid leukemia(CML) after liver transplantation has not been reported.
We report a case of living donor liver transplantation recipient who developed CML 14 months
following transplantation.
Patient and Methods:This patient is a case of Hepatitis B virus-related liver cirrhosis with recurrent
hepatocellular carcinoma(HCC) after previously successful trans-arterial embolization. The patient’s
liver transplant was uneventful. The immunosuppression used was tacrolimus-mycophenolate-
prednisolone-based. Post-transplant he received 10 cycles of doxorubicin-based(10mg/m2)
chemotherapy due to microscopic portal vein thrombosis seen in explant liver histopathology.
CML was diagnosed by bone marrow biopsy and chromosomal analysis. CML cytoreduction was
managed by hydroxyurea and imatinib.
Results:The patient is alive up to present writing 40 months post transplant without any episode
of liver graft rejection or HCC recurrence.
Figure1 -Bone marrow biopsy shows dense proliferation of hematopoetic cells comprsing mostly
of intermediate stage and mature myeloid cells suggestive of chronic myeloid leukemia. Hematoxylin
and eosin stain x 100(intel H&E x400)
Conclusion:Leukemias, although rare following solid organ transplantation, should be considered
in the differential diagnosis of hematological abnormalities.
